HighVista Strategies »

Akamai Technologies shares owned by HighVista Strategies

Quarter-by-quarter ownership of Akamai Technologies (AKAM) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Akamai Technologies

Tip: Access up to 7 years of quarterly data

All positions including Akamai Technologies held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akamai Technologies by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2026-06-30 $579k 4.9k 118.21

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Definium Therapeutics Com Shs (DFTX)
Immunovant (IMVT)
Praxis Precision Medicines I Com New (PRAX)
Relay Therapeutics (RLAY)
Alkermes SHS (ALKS)
Vaxcyte (PCVX)
Tango Therapeutics (TNGX)
Liquidia Corporation Com New (LQDA)
Cogent Biosciences (COGT)
Structure Therapeutics Sponsored Ads (GPCR)
Enliven Therapeutics (ELVN)
Amylyx Pharmaceuticals (AMLX)

View all positions for HighVista Strategies

Top funds holding Akamai Technologies

Jane Street
BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
Capital World Investors
Wells Fargo & Company
State Street Corporation
First Trust Advisors
Citadel Advisors
Geode Capital Management
Susquehanna International
Invesco
Bank of America Corporation
Royal Bank of Canada
Barclays

View all funds holding Akamai Technologies